Keyword Suggestion
Domain Informations
Lenvima.com lookup results from whois.1api.net server:
- Domain created: 2012-09-26T02:08:22Z
- Domain updated: 2023-06-13T07:24:00Z
- Domain expires: 2024-09-26T02:08:22Z 0 Years, 154 Days left
- Website age: 11 Years, 210 Days
- Registrar Domain ID: 1747765967_DOMAIN_COM-VRSN
- Registrar Url: http://www.1api.net
- Registrar WHOIS Server: whois.1api.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +49.68949396850
- Name server:
- NS-1149.AWSDNS-15.ORG
- NS-1644.AWSDNS-13.CO.UK
- NS-235.AWSDNS-29.COM
- NS-815.AWSDNS-37.NET
Network
- inetnum : 208.74.144.0 - 208.74.147.255
- name : FINANCIAL-SERVICES-INC
- handle : NET-208-74-144-0-1
- status : Direct Allocation
- created : 2011-02-03
- changed : 2024-03-06
Owner
- organization : Fidelity National Information Services, Inc.
- handle : FNIS-6
- address : Array,Jacksonville,FL,32202,US
Technical support
- handle : NWIPS-ARIN
- name : NWIP Services
- phone : +1-414-362-1646
- email : [email protected]
Abuse
- handle : NWIPS-ARIN
- name : NWIP Services
- phone : +1-414-362-1646
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 208.74.145.245
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 208.74.145.245)
Spam Check (IP: 208.74.145.245)
Recent Searched Sites
› 247restream.com (4 seconds ago) / US
› Johnhoward.on.ca (55 seconds ago) / US
› Sociopolis.md (3 seconds ago) / GB
› Kirali.in (17 seconds ago) / US
› Vkr.pspu.ru (13 seconds ago) / RU
› Uniqs.com.ar (33 seconds ago) / AR
› 7d2dmodlauncher.org (6 seconds ago) / CA
› Extranet.inegi.org.mx (32 seconds ago) / MX
› Hannoush.com (4 seconds ago) / US
› Designwithoutborders.com (19 seconds ago) / US
› Gamerdam.com (3 seconds ago) / US
› Bwrsd.org (37 seconds ago) / US
› Daveingram.us (11 seconds ago) / US
› Servir.marn.gob.sv (1 seconds ago) / SV
› Lenvima.com (1 seconds ago) / US
› Bbs.gxsd.com.cn (5 seconds ago) / CN
› Portal.sethu.ac.in (28 seconds ago) / IN
› Speedograph-richfield.com (8 seconds ago) / GB
› Diasys-diagnostics.com (9 seconds ago) / DE
› Mail.minutoverde.cl (5 seconds ago) / ES
Websites Listing
We found Websites Listing below when search with lenvima.com on Search Engine
Lenvima | Home
LENVIMA may cause serious side effects, including: high blood pressure (hypertension): High blood pressure is a common side effect of LENVIMA and can be serious. Your blood pressure should be well controlled before you start …
Ourlenvima.comlenvima - UpToDate
Lenvatinib – Lenvatinib is an inhibitor of VEGFR, and to a lesser degree, RET and fibroblast growth factor receptor kinases 1 to 4. In 2015, lenvatinib was approved by the US Food …. …
Uptodate.comLenvima for Renal Cell Carcinoma – Details | CADTH
Lenvatinib (Lenvima) RCC – Clinician COI Declarations. COI Declarations. January 4, 2019. ‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient …
Cadth.caEisai Announces Real-World Evidence on the Clinical
Oct 21, 2022 · About LENVIMA ® (lenvatinib); available as 10 mg and 4 mg capsules LENVIMA, discovered and developed by Eisai, is a multiple receptor tyrosine kinase inhibitor that inhibits …
Tmcnet.comEisai Announces Real-World Evidence on the Clinical Effectiveness …
Oct 21, 2022 · Eisai Announces Real-World Evidence on the Clinical Effectiveness of LENVIMA® (lenvatinib) Monotherapy for the Treatment of Patients with Radioiodine-Refractory …
Markets.ft.comEisai Announces Real-World Evidence on the Clinical Effectiveness …
Oct 21, 2022 · About LENVIMA (R) (lenvatinib); available as 10 mg and 4 mg capsules LENVIMA, discovered and developed by Eisai, is a multiple receptor tyrosine kinase inhibitor …
Marketwatch.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
hoodtech.com | godaddy.com | 2 Years, 38 Days |
kjjachi.com | gabia.com | -1 Years, -119 Days |
thefreesky.com | cloudflare.com | -1 Years, -342 Days |
leetsolve.com | godaddy.com | 1 Year, 6 Days |
estepais.com | register.com | -1 Years, -261 Days |
blackfriday-france.com | ionos.com | -1 Years, -105 Days |
utopiasiztapalapa.com | godaddy.com | -1 Years, -279 Days |
rocana.org | networksolutions.com | 2 Years, 62 Days |
virgo.co | whois.godaddy.com | -2 Years, -4 Days |
theproudliberal.org | whois.godaddy.com | -1 Years, -270 Days |